Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway
Lehe Yang,1–3,* Jifa Li,1,* Lingyuan Xu,1–3,* Shichong Lin,1–3 Youqun Xiang,3 Xuanxuan Dai,3 Guang Liang,2 Xiaoying Huang,3 Jiandong Zhu,1 Chengguang Zhao1,2 1Department of Respiratory Medicine, Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, Zhejiang...
Main Authors: | Yang L, Li J, Xu L, Lin S, Xiang Y, Dai X, Liang G, Huang XY, Zhu J, Zhao C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-02-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/rhein-shows-potent-efficacy-against-non-small-cell-lung-cancer-through-peer-reviewed-article-CMAR |
Similar Items
-
Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
by: Lehe Yang, et al.
Published: (2019-01-01) -
Rhein sensitizes human colorectal cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
by: Zhuang Y, et al.
Published: (2019-07-01) -
Antitumor Effects of Ursolic Acid through Mediating the Inhibition of STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer Cells
by: Dong Young Kang, et al.
Published: (2021-03-01) -
Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models
by: Emma Polonio-Alcalá, et al.
Published: (2020-05-01) -
Rhein Suppresses Colorectal Cancer Cell Growth by Inhibiting the mTOR Pathway In Vitro and In Vivo
by: Haibo Zhang, et al.
Published: (2021-04-01)